Ul Solutions Inc. (ULS) Insider Trading

Last 12 months

Insiders bought $10k and sold $12M on the open market.

85% of the selling was scheduled in advance under 10b5-1 plans. EVP & CCO Alberto Uggetti sold $610k on May 11, 37% of their stake, outside a plan.

Net open-market

−$12M

2 buys · 13 sales

Under a 10b5-1 plan

85%

of the value sold

Insiders who bought / sold

2 / 5

executives and directors

Last open-market buy

Dec 2025

Dec 8, 2025

Get an email when ULS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 8	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan	12,500	$70.08	$876k	5.5%	Form 4
Sep 1	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 2 parts	12,500	$73.67 average	$921k	5.2%	Form 4
Aug 3	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 3 parts	12,500	$92.08 average	$1.15M	4.9%	Form 4
Jul 1	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 5 parts	12,500	$99.22 average	$1.24M	4.7%	Form 4
Jun 9	Karen K Pepping Senior VP & CAO	Sold10b5-1 plan	725	$97.74	$71k	8.2%	Form 4
Jun 2 – 3	Gitte Schjotz See Remarks	Sold10b5-1 plan 2 parts	21,880	$98.48 average	$2.15M	27%	Form 4
Jun 1	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 2 parts	12,500	$100.00 average	$1.25M	4.5%	Form 4
May 28	Alberto Uggetti EVP & CCO	Sold10b5-1 plan	2,345	$99.89	$234k	23%	Form 4
May 21	Friedrich Hecker Director	SoldNo plan	4,000	$102.04	$408k	23%	Form 4
May 11	Alberto Uggetti EVP & CCO	SoldNo plan	6,100	$100.00	$610k	37%	Form 4
May 7	Gitte Schjotz See Remarks	SoldNo plan	8,000	$103.96	$832k	9.0%	Form 4
May 1	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 2 parts	12,500	$91.57 average	$1.14M	4.3%	Form 4
Apr 1	Jennifer F. Scanlon President and CEO	Sold10b5-1 plan 2 parts	12,500	$85.50 average	$1.07M	4.1%	Form 4
Dec 19, 2025	Ulse Inc. Large holder	SoldNo plan	1,875,000	$78.00	$146M	100%	Form 4
Mar 10, 2025 – Dec 8, 2025	John A Genovesi See Remarks	Bought 4 parts	145	$64.59 average	$9k	0.5%	Form 4
Dec 8, 2025	Lynn H Hancock See Remarks	Bought	8	$77.82	$623	<0.1%	Form 4
Dec 5, 2025	Ulse Inc. Large holder	SoldNo plan	12,500,000	$78.00	$975M	100%	Form 4
May 8, 2025	Alberto Uggetti EVP & CCO	SoldNo plan	1,961	$70.00	$137k	17%	Form 4
May 7, 2025	Gitte Schjotz See Remarks	SoldNo plan	7,000	$67.44	$472k	13%	Form 4
Mar 7, 2025	Alberto Uggetti EVP & CCO	SoldNo plan	1,938	$53.00	$103k	17%	Form 4
Dec 12, 2024	Gitte Schjotz See Remarks	SoldNo plan	21,000	$51.14	$1.07M	32%	Form 4
Dec 10, 2024 – Dec 11, 2024	Gitte Schjotz See Remarks	SoldNo plan 2 parts	2,918	$52.58 average	$153k	4.2%	Form 4
Dec 9, 2024	Gitte Schjotz See Remarks	SoldNo plan	5,941	$52.58	$312k	7.9%	Form 4
Dec 6, 2024	Gitte Schjotz See Remarks	SoldNo plan	1,466	$54.50	$80k	1.9%	Form 4

Oct 810b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at $70.08
$876k
5.5% of stake
Sep 110b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $73.67
$921k
5.2% of stake
Aug 310b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $92.08
$1.15M
4.9% of stake
Jul 110b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $99.22
$1.24M
4.7% of stake
Jun 910b5-1 plan
Karen K Pepping
Senior VP & CAO · sold 725 at $97.74
$71k
8.2% of stake
Jun 2 – 310b5-1 plan
Gitte Schjotz
See Remarks · sold 21,880 at avg $98.48
$2.15M
27% of stake
Jun 110b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $100.00
$1.25M
4.5% of stake
May 2810b5-1 plan
Alberto Uggetti
EVP & CCO · sold 2,345 at $99.89
$234k
23% of stake
May 21No plan
Friedrich Hecker
Director · sold 4,000 at $102.04
$408k
23% of stake
May 11No plan
Alberto Uggetti
EVP & CCO · sold 6,100 at $100.00
$610k
37% of stake
May 7No plan
Gitte Schjotz
See Remarks · sold 8,000 at $103.96
$832k
9.0% of stake
May 110b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $91.57
$1.14M
4.3% of stake
Apr 110b5-1 plan
Jennifer F. Scanlon
President and CEO · sold 12,500 at avg $85.50
$1.07M
4.1% of stake
Dec 19, 2025No plan
Ulse Inc.
Large holder · sold 1,875,000 at $78.00
$146M
100% of stake
Mar 10, 2025 – Dec 8, 2025
John A Genovesi
See Remarks · bought 145 at avg $64.59
$9k
0.5% of stake
Dec 8, 2025
Lynn H Hancock
See Remarks · bought 8 at $77.82
$623
<0.1% of stake
Dec 5, 2025No plan
Ulse Inc.
Large holder · sold 12,500,000 at $78.00
$975M
100% of stake
May 8, 2025No plan
Alberto Uggetti
EVP & CCO · sold 1,961 at $70.00
$137k
17% of stake
May 7, 2025No plan
Gitte Schjotz
See Remarks · sold 7,000 at $67.44
$472k
13% of stake
Mar 7, 2025No plan
Alberto Uggetti
EVP & CCO · sold 1,938 at $53.00
$103k
17% of stake
Dec 12, 2024No plan
Gitte Schjotz
See Remarks · sold 21,000 at $51.14
$1.07M
32% of stake
Dec 10, 2024 – Dec 11, 2024No plan
Gitte Schjotz
See Remarks · sold 2,918 at avg $52.58
$153k
4.2% of stake
Dec 9, 2024No plan
Gitte Schjotz
See Remarks · sold 5,941 at $52.58
$312k
7.9% of stake
Dec 6, 2024No plan
Gitte Schjotz
See Remarks · sold 1,466 at $54.50
$80k
1.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ULS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Testing Laboratories

NEONeoGenomics Inc.

MEDPMedpace Holdings Inc.

CRLCharles River Laboratories International, Inc.

INCYIncyte Corporation

NOTVInotiv Inc.

IQVIQVIA Holdings Inc.

ASTHAstrana Health Inc.

FCNFti Consulting Inc.

Spot a number that looks wrong? Check it in ULS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ULS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.